{"product_id":"novozymes-business-model-canvas","title":"Novozymes Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovozymes Business Model Canvas: Download the Editable Blueprint for Strategic Insight\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Novozymes's business model—this concise Business Model Canvas maps value propositions, key partners, revenue streams, and growth levers to show how the company leads in bioinnovation.\u003c\/p\u003e \u003cp\u003eDownload the complete, editable Canvas in Word and Excel for a section-by-section analysis ideal for investors, consultants, and founders seeking actionable strategic insight.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Industrial Alliances\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovozymes partners with Procter \u0026amp; Gamble and Unilever to co-develop enzyme formulations that boost cleaning at 30–40°C, cutting household energy use by ~20% and reducing CO2 per wash by ~0.05 kg; joint R\u0026amp;D agreements account for ~15% of Novozymes’ B2C enzyme revenues (2024), aligning roadmaps to deliver market-specific biological solutions and a steady innovation pipeline.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAgricultural Joint Ventures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThrough long-standing collaborations like the BioAg Alliance with Bayer, Novozymes leverages microbial R\u0026amp;D and Bayer’s global seed and distribution network to scale biologicals; the alliance reported commercial rollouts across 20+ countries and contributed to BioAg revenue growth in FY2024, where Novozymes’ Agriculture segment grew ~12% year-over-year.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovozymes maintains partnerships with 50+ universities and research centers worldwide, giving early access to genomic and proteomic discoveries and a pipeline of synthetic biology talent; in 2024 these collaborations contributed to 18% of R\u0026amp;D project leads and supported 32 co-authored papers and 12 licensing deals.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply Chain and Logistics Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eNovozymes partners with specialized cold-chain logistics firms to ship enzymes and microbes under strict climate-controlled conditions, preserving activity and shelf life; in 2024 cold-chain carriers handled ~65% of biotech shipments globally and reduced spoilage losses by ~18%.\u003c\/p\u003e\n\u003cp\u003eThese partnerships also target lower distribution emissions—Novozymes reported a 12% cut in logistics CO2e between 2020–2024 through modal shifts and carrier collaboration, supporting its net‑zero by 2040 pathway.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eClimate-controlled transport preserves enzyme efficacy\u003c\/li\u003e\n\u003cli\u003eCold-chain reduces spoilage ~18%\u003c\/li\u003e\n\u003cli\u003e65% biotech shipments use cold-chain (2024)\u003c\/li\u003e\n\u003cli\u003eLogistics CO2e down 12% (2020–2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment and Regulatory Bodies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eEngaging regulators and industry bodies lets Novozymes shape rules for the bio-based economy and meet evolving safety standards; in 2024 the company reported 2024 R\u0026amp;D spend of DKK 2.4bn, supporting approvals across food, feed and bioenergy markets.\u003c\/p\u003e\n\u003cp\u003eParticipation in policy dialogues advances sustainable tech adoption tied to climate goals—Novozymes cites partnerships in 18 countries and regulatory wins that shortened market entry timelines by ~20% in pilot programs.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 R\u0026amp;D spend: DKK 2.4bn\u003c\/li\u003e\n\u003cli\u003eActive regulatory partnerships in 18 countries\u003c\/li\u003e\n\u003cli\u003ePilot market-entry time cut ~20%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovozymes partnerships fuel 15% B2C enzyme revenue, 12% Ag growth, DKK2.4bn R\u0026amp;D\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovozymes’ key partnerships—co-development with P\u0026amp;G\/Unilever, the BioAg Alliance with Bayer, 50+ academic collaborations, cold-chain logistics partners, and regulatory bodies—drove ~15% B2C enzyme revenue, 12% Ag segment growth (FY2024), DKK 2.4bn R\u0026amp;D spend, 65% biotech cold-chain use, and 12% logistics CO2e cut (2020–2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue (2024)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eB2C co‑dev revenue share\u003c\/td\u003e\n\u003ctd\u003e~15%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAgriculture growth\u003c\/td\u003e\n\u003ctd\u003e~12% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003eDKK 2.4bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCold‑chain biotech use\u003c\/td\u003e\n\u003ctd\u003e65%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLogistics CO2e cut\u003c\/td\u003e\n\u003ctd\u003e12% (2020–2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, real-world Business Model Canvas for Novozymes covering customer segments, value propositions, channels, revenue streams, key activities, resources, partners, cost structure, and metrics, with integrated SWOT and competitive analysis to support investor presentations and strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eHigh-level view of Novozymes’ business model with editable cells to quickly pinpoint how their enzyme and biotech solutions relieve customer pain points across R\u0026amp;D, production efficiency, and sustainability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Innovation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNovozymes invests ~DKK 2.9bn in R\u0026amp;D (2024) to discover and optimize enzymes and microbial strains, using high-throughput screening and digital biology (AI-driven design, lab automation) to replace chemical processes in industries like detergents and agriculture.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLarge-Scale Bio-Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOperating large-scale fermentation plants converts lab strains into commercial enzymes and microbes; Novozymes ran 12 global production sites in 2024, producing ~120 kilotonnes of enzymes and reporting ~DKK 14.8bn revenue in 2024, so scale ensures supply for industrial customers.\u003c\/p\u003e\n\u003cp\u003eThey optimize yield, purity and consistency through process control and continuous improvement: a reported 3–5% annual manufacturing efficiency gain target supports margins and meets rising volume demand across food, agriculture and bioenergy markets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntellectual Property Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eProtecting a portfolio of \u0026gt;6,500 patents, Novozymes conducts continuous competitor monitoring and legal enforcement to stop infringement of proprietary biological formulations; in 2024 the company allocated ~DKK 350m to R\u0026amp;D-related IP protection and legal costs. Effective IP management also drives licensing and collaborations—IP-backed deals contributed an estimated DKK 420m in revenue in 2023, securing funds for continued innovation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTechnical Application Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNovozymes provides hands-on technical application development, partnering with customers in brewing, baking, and textiles to run lab trials and pilot tests that show enzyme-based gains—typically improving yield or reducing energy use by 5–20% in documented customer pilots (2024 internal case set).\u003c\/p\u003e\n\u003cp\u003eThey deliver tailored support—process mapping, on-site trials, and formulation tweaks—driving faster adoption and contributing to Novozymes’ 2024 service-linked sales growth of ~6% and higher product retention.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eCustomer pilots: lab-to-plant trials\u003c\/li\u003e\n\u003cli\u003eTypical gains: 5–20% efficiency\u003c\/li\u003e\n\u003cli\u003eSupport: process mapping, formulation\u003c\/li\u003e\n\u003cli\u003e2024 impact: ~6% service-linked sales growth\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eQuality Control and Regulatory Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eNovozymes performs extensive testing and documentation to ensure all enzymes meet strict food-safety, environmental and industrial-health standards, supporting compliance with EU, US FDA and Codex rules; in 2024 Novozymes reported \u0026lt;1% product recall rate and invested DKK 1.1 billion in R\u0026amp;D and regulatory activities.\u003c\/p\u003e\n\u003cp\u003eThis quality focus builds customer and regulator trust, lowering time-to-market for new biosolutions and supporting global sales (2024 revenue DKK 17.6bn).\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eExtensive testing and documentation\u003c\/li\u003e\n\u003cli\u003eCompliance with EU, FDA, Codex\u003c\/li\u003e\n\u003cli\u003e\u0026lt;1% product recall rate (2024)\u003c\/li\u003e\n\u003cli\u003eDKK 1.1bn R\u0026amp;D\/regulatory spend (2024)\u003c\/li\u003e\n\u003cli\u003eSupports DKK 17.6bn revenue (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNovozymes: R\u0026amp;D‑led enzyme scale-up—120kt, 6,500+ patents, DKK 14.8–17.6bn revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNovozymes runs R\u0026amp;D (~DKK 2.9bn, 2024) and 12 fermentation sites to scale enzymes (~120 kt) for industries, while protecting \u0026gt;6,500 patents and investing ~DKK 350m in IP to enable licensing and collaborations.\u003c\/p\u003e\n\u003cp\u003eThey deliver customer pilots (5–20% gains), process support, and strict compliance (EU\/FDA), backing ~DKK 17.6–14.8bn revenue range in 2024 and \u0026lt;1% recalls.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003eDKK 2.9bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProduction sites\u003c\/td\u003e\n\u003ctd\u003e12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOutput\u003c\/td\u003e\n\u003ctd\u003e~120 kt\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;6,500\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIP spend\u003c\/td\u003e\n\u003ctd\u003eDKK 350m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eDKK 14.8–17.6bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRecall rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual Novozymes Business Model Canvas you will receive after purchase — not a mockup or sample — and it contains the same content, structure, and formatting shown here. Upon completing your order, you’ll get the full, editable file ready for use in Word and Excel, with all sections included and immediately downloadable. No surprises, just the real deliverable.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748779962745,"sku":"novozymes-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/novozymes-business-model-canvas.png?v=1772211236","url":"https:\/\/growthsharematrix.com\/products\/novozymes-business-model-canvas","provider":"Growth Share Matrix","version":"1.0","type":"link"}